Literature DB >> 10199317

Reticuloendothelial system activity and organ failure in patients with multiple injuries.

H C Pape1, D Remmers, M Grotz, J Kotzerke, S von Glinski, M van Griensven, M Dahlweid, S Sznidar, H Tscherne.   

Abstract

HYPOTHESIS: Reticuloendothelial system function is altered in patients with multiple trauma and organ failure.
DESIGN: Prospective cohort study.
SETTING: Surgical intensive care unit at a level I trauma center. PATIENTS: Patients with multiple blunt trauma and injury severity scores greater than 20, with no referrals.
INTERVENTIONS: Every second day reticuloendothelial system (RES) clearance capacity and liver blood flow were determined by administering labeled human albumin. Liver function was measured by enzymatic decay of indocyanine green, and levels of plasma tumor necrosis factor alpha were evaluated.
RESULTS: In nonsurviving patients with blunt trauma, RES function was altered and was associated with organ dysfunction and infectious complications. Of 61 patients, 42 survived and 19 did not. Sixteen patients (84%) died of multiple organ failure. Significantly elevated RES activity (colloid clearance rate) was present between day 5 and day 13 after trauma in nonsurvivors (0.86+/-0.16 [mean +/- SD] on day 7, P = .003) compared with survivors (0.48+/-0.08 on day 7) and 20 healthy volunteers (0.47+/-0.06); RES activity then decreased to subnormal levels in nonsurvivors. Tumor necrosis factor alpha plasma levels were elevated early after injury only in nonsurvivors (on day 1: nonsurvivors, 1.2+/-0.4 ng/mL [mean +/- SD]; survivors, 0.5+/-0.2 ng/mL; P = .02). Indocyanine green half-life values increased late after trauma, indicating late organ failure (on day 19: nonsurvivors, 111+/-29 minutes [mean +/- SD]; survivors, 12+/-4 minutes; P<.001).
CONCLUSIONS: Early after trauma, nonsurviving patients demonstrated increased proinflammatory cytokine levels, followed by a state of pathological hyperactivation of the reticuloendothelial system prior to death. These results indicate that the stationary host defense system is involved in the mechanisms causing organ failure after severe trauma.

Entities:  

Mesh:

Year:  1999        PMID: 10199317     DOI: 10.1001/archsurg.134.4.421

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  6 in total

1.  Are alterations of lymphocyte subpopulations in polymicrobial sepsis and DHEA treatment mediated by the tumour necrosis factor (TNF)-alpha receptor (TNF-RI)? A study in TNF-RI (TNF-RI(-/-)) knock-out rodents.

Authors:  F Hildebrand; H-C Pape; P Harwood; T Wittwer; C Krettek; M van Griensven
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 2.  [Decision making and and priorities for surgical treatment during and after shock trauma room treatment].

Authors:  H C Pape; F Hildebrand; C Krettek
Journal:  Unfallchirurg       Date:  2004-10       Impact factor: 1.000

3.  Trauma care in Germany: an inclusive system.

Authors:  Johannes A Sturm; Hans-Christoph Pape; Thomas Dienstknecht
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

4.  The immune response after fracture trauma is different in old compared to young patients.

Authors:  Helen Vester; Markus S Huber-Lang; Qerim Kida; Alexander Scola; Martijn van Griensven; Florian Gebhard; Andreas K Nüssler; Mario Perl
Journal:  Immun Ageing       Date:  2014-12-11       Impact factor: 6.400

Review 5.  Reconciling the IPC and Two-Hit Models: Dissecting the Underlying Cellular and Molecular Mechanisms of Two Seemingly Opposing Frameworks.

Authors:  Carlos F M Morris; Muhammad Tahir; Samina Arshid; Mariana S Castro; Wagner Fontes
Journal:  J Immunol Res       Date:  2015-12-06       Impact factor: 4.818

Review 6.  Global changes in mortality rates in polytrauma patients admitted to the ICU-a systematic review.

Authors:  Johanna M M van Breugel; Menco J S Niemeyer; Roderick M Houwert; Rolf H H Groenwold; Luke P H Leenen; Karlijn J P van Wessem
Journal:  World J Emerg Surg       Date:  2020-09-30       Impact factor: 5.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.